Open AccessMetabolism and metabolic inhibition of gambogic acid in rat liver microsomes 1
Author(s) -
LIU Yitong,
HAO Kun,
LIU Xiaoquan,
WANG Guangji
Publication year - 2006
Publication title -
acta pharmacologica sinica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.514
H-Index - 90
eISSN - 1745-7254
pISSN - 1671-4083
DOI - 10.1111/j.1745-7254.2006.00369.x
Subject(s) - metabolite , microsome , metabolism , cytochrome p450 , biochemistry , cyp3a4 , chemistry , cyp1a2 , metabolic pathway , gambogic acid , enzyme , biology , pharmacology , in vitro
Aim: To study the metabolism of gambogic acid (GA) and the effects of selective cytochrome P‐450 (CYP450) inhibitors on the metabolism of GA in rat liver microsomes in vitro. Methods: Rat liver microsomes were used to perform metabolism studies. Various selective CYP450 inhibitors were used to investigate their effects on the metabolism of GA and the principal CYP450 isoform involved in the formation of major metabolite M 1 in rat liver microsomes. Types of inhibition in an enzyme kinetics model were used to model the interaction. Results: GA was rapidly metabolized to two phase I metabolites, M 1 and M 2 , in rat liver microsomes. M 1 and M 2 were tentatively presumed to be the hydration metabolite and epoxide metabolite of GA, respectively. α‐Naphthoflavone uncompetitively inhibited the formation of M 1 while ketoconazole, sulfaphenazole, diethyl dithiocarbamate and quinidine had little or no inhibitory effects on the formation of M 1 . Conclusion: GA is rapidly metabolized in rat liver microsomes and M 1 is crucial for the elimination of GA. Cytochrome P‐450 1A2 is the major rat CYP involved in the metabolism of GA.